
Klothea Bio has secured funding from Longevitytech.fund to pioneer breakthrough treatments for metabolic syndrome and several age-related diseases. Advantage Therapeutics, which develops therapies targeting age-related diseases,...

Multinational pharmaceutical company AstraZeneca has teamed up with ‘young’ Chinese biotech Cholesgen to develop new drugs to target high cholesterol and related metabolic diseases. The three-year...